Stroke following variceal sclerotherapy

European Journal of Medical Research

Volumn 9, Issue 5, 2004, Pages 282-284

  Hanisch, Frank ^a   Muller T ^a   Krivokuca, M ^a   Winterholler, M ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Neurologische Klinik   (Germany)

Author keywords

Aggravation; Bending down; Central senstitization; Head movements; Migraine; Physical activity

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CEREBROVASCULAR ACCIDENT; FEMALE; HEART SEPTUM DEFECT; HUMAN; MIDDLE AGED; PARADOXICAL EMBOLISM; SCLEROTHERAPY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VARICOSIS;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIDDLE AGED; SCLEROTHERAPY; VARICOSE VEINS;

EID: 16544372452     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ariyoshi H, Kambayashi J, Tominaga S, Hatanaga T. The possible risk of lower-limb sclerotherapy causing an extended hypercoagulable state. Surg Today 1996: 26: 323-7
2. Beresford SAA, Chant ADB, Jones HD, Piachaud D, Wedell JM. Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Lancet 1978: 1: 921-4
3. Bohler-Sommeregger K, Karnel F, Schuller-Petrovic S, Santler R. Do telangiectases communicate with the deep venous system? J Dermatol Surg Oncol 1992: 18: 403-6.
4. Chaikof EL, Campbell BE, Smith RB 3rd. Paradoxical embolism and acute arterial occlusion: rare or unsuspected? J Vasc Surg 1994: 20: 377-84
5. Conrad P, Malouf GM, Stacey MC. The Australian Polidocanol Study. Dermatol Surgery 1995: 21: 334-6
6. Goldman MP. Complications and adverse sequelae of sclerotherapy. In: Goldman MP, ed. Treatment of varicose and teleangiectatic leg veins. St. Louis: Mosby, Year Book, XXII, 1995: 519
7. Goor W, Leu HJ, Mahler F. Thrombosen in tiefen Venen und in Arterien nach Varizensclerosierung. Vasa 1987: 16: 124-9
8. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1994: 59: 17-20
9. Hanafi M, Orliaguet G, Meyer P, Blanot S, Brunelle F, Carli P. Pulmonary embolism in sclerotherapy for a venous malformation in a child under general anesthesia. Ann Fr Anesth Reanim 2001: 20: 556-8
10. Konstantinides S, Just H. Treatment of patients with patent foramen ovale: oral anticoagulation vs. surgical closure. Z Kardiol 2000: 89: 63-71
11. Lamy C, Giannesini C, Zuber M, Arquizan C, et al. Clinical and imaging findings in cryptogenic stroke. Patients with and without patent foramen ovale: The PFO-ASA study. Stroke 2002: 33: 706-11
12. Lethen H, Flachskampf FA, Schneider R, Sliwka U, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997: 80: 1066-9
13. Nassif A, Coevoet V, Resten A, Aiken N, Maitre S, Musset D. Pulmonary embolization from migration of sclerotherapy material. J Radiol 2001: 82: 583-5
14. Noppeney Th, Noppeney J, Scheidt A, Kurth I. Indications and technique for sclerotherapy of varicose veins. Zentralbl Chir 2001: 126: 546-50
15. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993: 24: 31-4
16. Reid RG, Rothnie NG. Treatment of varicose veins by compression sclerotherapy. Br J Surg 1968: 55: 889-95
17. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993:119: 461-5.